These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 20181616)
21. Repression of vascular endothelial growth factor expression by the runt-related transcription factor 1 in acute myeloid leukemia. Ter Elst A; Ma B; Scherpen FJ; de Jonge HJ; Douwes J; Wierenga AT; Schuringa JJ; Kamps WA; de Bont ES Cancer Res; 2011 Apr; 71(7):2761-71. PubMed ID: 21447743 [TBL] [Abstract][Full Text] [Related]
22. Hsp90alpha recruited by Sp1 is important for transcription of 12(S)-lipoxygenase in A431 cells. Hung JJ; Wu CY; Liao PC; Chang WC J Biol Chem; 2005 Oct; 280(43):36283-92. PubMed ID: 16118214 [TBL] [Abstract][Full Text] [Related]
23. Dynamic combinatorial interactions of RUNX1 and cooperating partners regulates megakaryocytic differentiation in cell line models. Pencovich N; Jaschek R; Tanay A; Groner Y Blood; 2011 Jan; 117(1):e1-14. PubMed ID: 20959602 [TBL] [Abstract][Full Text] [Related]
24. The leukemia associated ETO nuclear repressor gene is regulated by the GATA-1 transcription factor in erythroid/megakaryocytic cells. Ajore R; Dhanda RS; Gullberg U; Olsson I BMC Mol Biol; 2010 May; 11():38. PubMed ID: 20487545 [TBL] [Abstract][Full Text] [Related]
25. A chromatin immunoprecipitation screen reveals protein kinase Cbeta as a direct RUNX1 target gene. Hug BA; Ahmed N; Robbins JA; Lazar MA J Biol Chem; 2004 Jan; 279(2):825-30. PubMed ID: 14561740 [TBL] [Abstract][Full Text] [Related]
26. Runx1 is a co-activator with FOXO3 to mediate transforming growth factor beta (TGFbeta)-induced Bim transcription in hepatic cells. Wildey GM; Howe PH J Biol Chem; 2009 Jul; 284(30):20227-39. PubMed ID: 19494111 [TBL] [Abstract][Full Text] [Related]
27. Platelet 12-lipoxygenase activation via glycoprotein VI: involvement of multiple signaling pathways in agonist control of H(P)ETE synthesis. Coffey MJ; Jarvis GE; Gibbins JM; Coles B; Barrett NE; Wylie OR; O'Donnell VB Circ Res; 2004 Jun; 94(12):1598-605. PubMed ID: 15142951 [TBL] [Abstract][Full Text] [Related]
28. Transcriptional activation of human 12-lipoxygenase gene promoter is mediated through Sp1 consensus sites in A431 cells. Liu YW; Arakawa T; Yamamoto S; Chang WC Biochem J; 1997 May; 324 ( Pt 1)(Pt 1):133-40. PubMed ID: 9164849 [TBL] [Abstract][Full Text] [Related]
29. Transcriptional regulation of the human MIP-1alpha promoter by RUNX1 and MOZ. Bristow CA; Shore P Nucleic Acids Res; 2003 Jun; 31(11):2735-44. PubMed ID: 12771199 [TBL] [Abstract][Full Text] [Related]
30. MiR-18a increased the permeability of BTB via RUNX1 mediated down-regulation of ZO-1, occludin and claudin-5. Miao YS; Zhao YY; Zhao LN; Wang P; Liu YH; Ma J; Xue YX Cell Signal; 2015 Jan; 27(1):156-67. PubMed ID: 25452107 [TBL] [Abstract][Full Text] [Related]
31. Transcriptional Auto-Regulation of RUNX1 P1 Promoter. Martinez M; Hinojosa M; Trombly D; Morin V; Stein J; Stein G; Javed A; Gutierrez SE PLoS One; 2016; 11(2):e0149119. PubMed ID: 26901859 [TBL] [Abstract][Full Text] [Related]
32. p63 directly induces expression of Alox12, a regulator of epidermal barrier formation. Kim S; Choi IF; Quante JR; Zhang L; Roop DR; Koster MI Exp Dermatol; 2009 Dec; 18(12):1016-21. PubMed ID: 19555433 [TBL] [Abstract][Full Text] [Related]
33. Subnuclear targeting of Runx1 is required for synergistic activation of the myeloid specific M-CSF receptor promoter by PU.1. Li X; Vradii D; Gutierrez S; Lian JB; van Wijnen AJ; Stein JL; Stein GS; Javed A J Cell Biochem; 2005 Nov; 96(4):795-809. PubMed ID: 16149049 [TBL] [Abstract][Full Text] [Related]
34. Tumor necrosis factor‑related apoptosis‑inducing ligand is a novel transcriptional target of runt‑related transcription factor 1. Yoshida T; Yamasaki K; Tadagaki K; Kuwahara Y; Matsumoto A; Sofovic AE; Kondo N; Sakai T; Okuda T Int J Oncol; 2022 Jan; 60(1):. PubMed ID: 34958111 [TBL] [Abstract][Full Text] [Related]
35. AML1/ETO proteins control POU4F1/BRN3A expression and function in t(8;21) acute myeloid leukemia. Dunne J; Gascoyne DM; Lister TA; Brady HJ; Heidenreich O; Young BD Cancer Res; 2010 May; 70(10):3985-95. PubMed ID: 20460523 [TBL] [Abstract][Full Text] [Related]
36. Effects of silencing leukocyte-type 12/15-lipoxygenase using short interfering RNAs. Li SL; Dwarakanath RS; Cai Q; Lanting L; Natarajan R J Lipid Res; 2005 Feb; 46(2):220-9. PubMed ID: 15576842 [TBL] [Abstract][Full Text] [Related]
37. 15-Lipoxygenation of leukotriene A(4). Studies Of 12- and 15-lipoxygenase efficiency to catalyze lipoxin formation. Tornhamre S; Elmqvist A; Lindgren JA Biochim Biophys Acta; 2000 Apr; 1484(2-3):298-306. PubMed ID: 10760478 [TBL] [Abstract][Full Text] [Related]
38. Molecular cloning and expression of human arachidonate 12-lipoxygenase. Yoshimoto T; Yamamoto Y; Arakawa T; Suzuki H; Yamamoto S; Yokoyama C; Tanabe T; Toh H Biochem Biophys Res Commun; 1990 Nov; 172(3):1230-5. PubMed ID: 2244907 [TBL] [Abstract][Full Text] [Related]
39. Dysmegakaryopoiesis of FPD/AML pedigrees with constitutional RUNX1 mutations is linked to myosin II deregulated expression. Bluteau D; Glembotsky AC; Raimbault A; Balayn N; Gilles L; Rameau P; Nurden P; Alessi MC; Debili N; Vainchenker W; Heller PG; Favier R; Raslova H Blood; 2012 Sep; 120(13):2708-18. PubMed ID: 22898599 [TBL] [Abstract][Full Text] [Related]
40. Biology and pharmacology of platelet-type 12-lipoxygenase in platelets, cancer cells, and their crosstalk. Contursi A; Tacconelli S; Hofling U; Bruno A; Dovizio M; Ballerini P; Patrignani P Biochem Pharmacol; 2022 Nov; 205():115252. PubMed ID: 36130648 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]